12:29 PM EST - Transition Therapeutics Inc. : reported second-quarter net loss and comprehensive loss of $6.06 million or $0.26 per share, compared to a loss of $4.87 million or $0.21 per share in the previous-year quarter. For the quarter, the company recognized revenue of $988,000 as compared to nil in the prior year quarter. For six months, the company reported net loss and comprehensive loss of $11.67 million or $0.50 per share, compared to a loss of $9.91 million or $0.43 per share in last year. Licensing fees for the six-month period was $1.29 million. Transition Therapeutics Inc.
shares T.TTH are trading down $0.08 at $2.63.
